Professor Greg Hannon,
Prof Hannon joined the Institute in 2014 as a Senior Group Leader, after spending more than 20 years at Cold Spring Harbor Laboratory in New York. He became Director on 1 February 2018, taking over from Professor Simon Tavaré. Read more.
Director of Operations
Karen Woodey joined as Director of Operations on 1 August 2019. Karen is responsible for all aspects of the operation of the Institute including long-term strategic planning and providing support and infrastructure to the Director.
Scientific Advisory Board
The Institute is guided and supported by an international Scientific Advisory Board.
The Board visits the Institute annually and is shared with the CRUK Cambridge Centre, to ensure the two are working in alignment.
Prof Douglas Fearon,
Cold Spring Harbor Laboratory
The Fearon laboratory studies the interaction between cancer and the immune system. Read more.
Prof Elaine Fuchs,
The Rockefeller University
Fuchs is renowned for her research in skin biology, its stem cells and associated genetic disorders, particularly cancers. Read more.
Prof Daphne Haas-Kogan
Dana-Farber Cancer Institute
Haas-Kogan’s research focuses on characterizing aberrant signaling pathways in brain tumors and pediatric cancers and investigating agents that target these signaling cascades.
Prof Peter Jones,
Van Andel Research Institute
Jones’ laboratory discovered the effects of 5-azacytidine on cytosine methylation and first established the link between DNA methylation, gene expression and differentiation. Read more.
Prof Johanna Joyce,
University of Lausanne
Johanna Joyce’s laboratory investigates the microenvironment in which a tumour arises and the critical influence that non-cancerous immune and stromal cells can have on tumour progression and metastasis. Read more.
Dr Scott Lowe,
Memorial Sloan Kettering Cancer Centre
Lowe’s laboratory applies mouse models, functional genomics and cancer genomics in a coordinated effort to identify cancer drivers and dependencies. Read more.
Prof Karen Vousden,
Francis Crick Institute
Vousden’s research has contributed to our understanding of how the tumour suppressor protein p53 is regulated and functions to control cancer progression. Read more.